News Daily News Weight Loss Drugs Show Promise for Secondary Prevention in PAD L.A. McKeown February 04, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2026 Caitlin E. Cox February 02, 2026
News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2025 Michael O'Riordan June 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2025 Caitlin E. Cox May 30, 2025
News Conference News European Congress on Obesity 2025 SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly Michael O'Riordan May 14, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Opinion Editor's Corner TCTMD’s Biggest News of 2024: Stories, Videos, and More Shelley Wood January 01, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2024 Caitlin E. Cox December 31, 2024
News Conference News EACTS 2024 ‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow Yael L. Maxwell October 17, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024